Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on August 14, 2025

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, spotlights LIXTE Biotechnology Holdings (Nasdaq: LIXT), a clinical-stage …

Uphold Customers Can Now Add Funds to Wallets Instantly Using PayPal
SAN FRANCISCO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Uphold, the modern infrastructure provider for on-chain payments, banking, and investments, has announced a new integration with PayPal, enabling U.S. users to fund their Uphold wallets instantly through …

PalCare and ALIS Partner to Launch Innovative Two-Way EHR Integration for Smarter Senior Living Workflows
MILWAUKEE, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PalCare, a leader in nurse call and resident safety technology, announced a strategic partnership with ALIS, a premier EHR platform for senior living, to launch a two-way integration between the PalCare Portal …

Cerence Audio AI Integrates with HARMAN AudioworX to Enhance In-Car Experiences
BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced the integration of its industry-leading Audio AI suite into HARMAN’s …

Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide
Company and Former Cincinnati Bengals Running Back Known for the “Ickey Shuffle” Collaborate to Raise Awareness and Drive Asthma Education with Focus on Acute Attacks SAN DIEGO and CINCINNATI, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings …

Global Pulse Oximeters Market Set to Surpass USD 7.03 Billion by 2032 | MarketsandMarkets™
Delray Beach, FL, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Advanced patient monitoring solutions see rising adoption amid aging populations, chronic disease prevalence, and healthcare infrastructure expansion The global pulse oximeters market, valued at US$3.59 …

Halda Therapeutics Receives FDA Fast Track Designation for HLD-0915 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NEW HAVEN, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of therapies called RIPTAC™ Therapeutics, today announced that the U.S. Food and Drug Administration (FDA) granted Fast …

Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Favorable CDI-988 Phase 1 safety and tolerability reported Challenge study with CDI-988 as a norovirus preventive and treatment planned later this year BOTHELL, Wash., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or …

Duos Edge AI and FiberLight Expand Strategic Partnership
JACKSONVILLE, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data …

Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
Echocardiographic data analysis demonstrated favorable impact of atrioventricular interval modulation (“AVIM”) therapy on MODERATO II study patients with diastolic dysfunction, a key component in the development of heart failure with preserved ejection …

ProStar and JAVAD GNSS Announce Worldwide Distribution Deal
GRAND JUNCTION, Colo., Aug. 14, 2025 (GLOBE NEWSWIRE) -- ProStar® Holdings Inc. (“ProStar®” or “the Company”) (TSXV: MAPS, OTCQX: MAPPF, FSE: 5D00), the developer of PointMan® Precision Mapping Solutions®, and JAVAD GNSS, a world leader in patented GNSS ( …

Analytics For Life Completes Clinical Study of Non-Invasive Point-of-Care Test for Elevated Pulmonary Capillary Wedge Pressure (PCWP) Using Machine Learning
Study achieves primary sensitivity endpoint, advancing diagnostics for heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH) Results build on data previously presented at ACC.25 in March 2025 TORONTO and BETHESDA, Md., Aug. …

Omegro Enters the UK Fleet Management Vertical with the Acquisition of Verilocation
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Today Omegro announced the acquisition of Verilocation, a provider of fleet management and telematics software solutions. Based in Northampton, UK, Verilocation capitalises on its deep expertise in fleet …

VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update
BRIDGEWATER, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune- …

Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
—Phase 3 Preparations Ongoing as Company Continues to Advance Multiple Partnering Options for Executing the Nebokitug Phase 3 Program— —Phase 2 SPRING Trial Data Highlighting Nebokitug’s Unique Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects …

CTW Cayman to Ring NASDAQ Opening Bell on August 18, 2025
TOKYO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- CTW Cayman (Nasdaq: CTW) (“CTW” or “the Company”), a leading game platform company providing global access to web-based games through its flagship HTML5 platform, G123.jp, which showcases a diverse selection of free …

PharmaTher Founder and CEO Issues Letter to Shareholders following the FDA Approval of Ketamine (KETARx™)
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, announced today that Fabio …

Cycurion, Inc. Reports Financial Results for the Second Quarter of 2025
MCLEAN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a premier cybersecurity and IT solutions provider, today announced its financial results for the second quarter and first half of 2025. Amid …

ModelOp Launches Good Decisions, a New Podcast About Human Decision Making in the Age of AI
CHICAGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ModelOp, the leading AI lifecycle automation and governance software for enterprises, announced today the launch of its new podcast Good Decisions. From CIA officers turned CTOs to tech pioneers and data …

Healthcare Innovation Summit Africa Returns to Johannesburg - Registration Now Open
JOHANNESBURG, South Africa, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Healthcare Innovation Summit Africa (HISA) 2025, Africa’s leading platform for exploring the latest trends and technologies shaping the healthcare industry, will return to Johannesburg on 22 …